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IN VITRO STUDIES ON VITILIGO*
FUNAN HE, M.D., ROBERT P. FOSNAIJGH, M.D. AND PATRICIA F. LESNEY
Vitiligo is an acquired condition which is
associated with the loss of pigment without other
apparent histological changes in the skin. In
general, it is believed that the melanocytes
actually are present in the involved skin but are
in an inhibited state of functional activity. Our
present study reports on the cytological findings
of various pigment cells in the normally pig-
mented and depigmented skins of 18 cases of
vitiligo. We also made cytological observations
on the melanocytes of the repigmented areas in
vitiligo patients who had either repigmented
spontaneously or following treatment.
MATERIALS AND METHODS
Split thickness skin specimens were obtained
from areas which had been infiltrated with Xylo-
caine®. The skins, thus obtained, contained the
whole epidermis and a very small amount of
dermis. A definite attempt was made to take our
normal control specimens from an area of skin
which was similar in location to that which was
vitiliginous. This was done in order to obtain a
better appreciation of any increase or decrease in
number of melanocytes present. The difference in
number of melanocytes in different locations in
the same individual is well known (1, 2).
Specimens were again taken anywhere from a
few months to 2 years following treatment with
systemic methoxsalen in conjunction with ultra-
violet light. If possible, these specimens included:
1) repigmented sites, 2) vitiligo areas which failed
to repigment, 3) mottled areas with isolated spots
of perifollicular repigmentation, and 4) the border
between pigmented and nonpigmented areas.
The specimens were then divided into two parts
and subjected to the following studies:
I. Splitting with sodium bromide
Both normal and vitiliginous skins were split
with 2N sodium bromide solution, following the
procedure described by Staricco and Pinkus (2).
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By this technic the epidermis was easily separated
from the corium. The sheet of epidermis was then
subjected to the following reagents:
1) Dopa reaction (3).
2) Silver reduction technic for the demonstra-
tion of argentaffine granules (4). A slight modifica-
tion of Masson's ammoniacal silver nitrate technic
was employed; this appeared to give more con-
sistent results in our hands.
3) Supra-vital staining with methylene blue (5)
II. Tissue culture studies
The skin biopsy specimens were cut into pieces
approximately 2 x 2 mm. square and explanted
with the roller tube tissue culture method (6).
After incubation at 37° C. for three to four weeks,
the cultures were studied with the same procedures
employed in the split skins. In addition to these
technics, the specimens were stained for detailed
cytological examination with May-Gruenwald-
Giemsa reagents (7).
RESULTS
Among a total of 18 cases of vitiligo studied,
15 were diagnosed as typical vitiligo, 2 cases as
congenital vitiligo, and one case as pseudo-
vitiligo.
I. Split skin examinations—The results were
summarized in Table I
1) Typical vitiligo
On examination, there were no histochemically
recognizable melanocytes observed in the vitiligi-
nous skins of all 15 of our patients with typical
vitiligo; normal melanocytes were present in
the normally pigmented skins of these individuals
(Fig. 1). In the vitiliginous areas, however, there
were small, round, ovoid or slightly stellate cells
which appeared more or less homogeneously
gray or black in the dopa treated specimens
(Fig. 2). Morphologically, these cells resembled
the dopa-positive melanocytes seen in Caucasian
or lightly pigmented skins. However, they differed
from the latter in that they did not have a granu-
lar cytoplasm. These cells probably represent
"inactive" melanocytes. It must be kept in
mind that almost all cells take up some brownish
black coloration when subjected to prolonged
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incubation in the dopa reagent. This black colora-
tion is due to a non-specific darkening effect
of the chemical and is not a true dopa reaction.
A dopa-positive melanocyte may appear to be
almost solid black when it is strongly reactive,
but if examined carefully, it is always somewhat
granular in appearance. In the less intense re-
action, the granularity of the cytoplasm is very
apparent. We feel that cytoplasmic granularity
is an important requisite for a true positive dopa
reaction. In the vitiliginous areas in 11 out of
the 15 skins examined there were a few of the
homogeneously black stained small cells men-
tioned above. However, no typical dopa-positive
melanocytes were observed (Figs. 3, 4, 5).
Supra-vital methylene blue staining of the
vitiliginous skins revealed the presence of small
numbers of isolated cells which were either
round, ovoid, or stellate in shape and which
appeared to take a little more blue staining than
the adjacent polyhedral epithelial cells. However,
it was impossible to always distinguish small
stellate cells from isolated epithelial cells. We
were not positive whether these cells represented
the so-called "white" dendritic cells as described
by Billingham (5) or whether they simply repre-
sented epithelial cells dissociated incidental to
the chemical splitting of the preparation.
The rounded to slightly stellate cells which
were found in the vitiliginous areas apparently
did not fulfill all the criteria which we customarily
use to define a mclanocyte; therefore we do not
feel justified in classifying them as normal
melanocytes. If we can be reasonably sure that
they are not dissociated epithelial cells, then we
can tentatively consider them as "inactive"
melanocytes. From this point on we will refer to
these cells as such in this paper.
Silver treated preparations gave the following
findings. With the exception of two cases which
will be discussed later, no silver positive granules
were present in any of the vitiliginous skins
examined.
In 2 of our 15 patients with typical vitiligo,
there were findings which deserved special at-
tention. Prior to the institution of any treatment
we found small islands of cells with intracyto-
plasmic argentaffine granules in the vitiliginous
areas. The dopa reaction in the same areas was
negative. It is indeed interesting that these 2
patients were found to clinically repigment far
more readily and more extensively following
methoxsalcn and ultraviolet therapy than did
any of our other patients. These 2 patients were
unique in other respects; they also failed to lose
any of their repigmentation when mcthoxsalen
and ultraviolet light were discontinued for 6
months in one case and for 2 years in another.
Both of these individuals were non-Negro dark-
skinned people.
After treatment with methoxsalen and ultra-
violet light, normal silver positive, dopa-positive,
and methylene blue positive melanocytcs were
seen in both normally pigmented and repig-
mented areas. There was no discernible morpho-
logical difference between the melanocytes in
the normally pigmented and the repigmented
areas. These repigmented areas were of the same
tone or shade as the patient's normal skin. The
areas which failed to repigment after therapy
gave negative reactions to silver, dopa, and
methylcnc blue. The mottled areas of repig-
mentation and hyperpigmented borders of the
vitiliginous patches revealed melanocytes which
were positive with silver, dopa, and methylcnc
TABLE I
Cytological findings in different cases of vitiligo studied
Total Number
of cases TypicalMelanucytes
"Inactive"
Melanocytes
Argeutaffine
Granules Repigmentation
Typical Vitiligo
Pseudo Vitiligo
Congenital Vitiligo
15
1
2
0/15
1/1
1/2
11/15
1/2
2/15
1/1
2/2
marked improvement in
2 cases with argentaf-
fine granules
complete
marked improvement in
1; repigmentation in
the other*
* This case has not been followed long enough to be certain how complete the repigmentation is going
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FIGs. 1 and 2. Vitiligo. Split epidermis, Dopa. 100X
FIG. 1. Normally pigmented skin in vitiligo patient. Note the evenly distributed dnpa-positive mel-
anoeytes in the split epidermis.FIG. 2. Depigmented skin in the same patient. Note the few scattered dark cells.
blue. These melanocytes were distinctive in
that they were larger and more dendritie and
more complex than normal melanocytes (Figs.
6—12). Clinically, the skin in these areas was
more darkly pigmented than the normal skin.
Extensive in vitro examinations were done in
one of these 2 patients. The findings were sum-
marized in Table II.
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FIGS. 3, 4 and 5. Split epidermis, Dopa. 430X
FIG. 3. Normally pigmented skin in vitiligo patient.
FIG. 4. Depigmented skin in the same patient. Note the small dark "inactive" melanocytes.
FIG. 5. Depigmented skin in the same patient. The small aggregates of dark cells are keratinized
epithelial cells which have stained non-specifically with the dopa reagent.
) Pseudovitiligo
This patient was so designated because he
did not fulfill all of the clinical and laboratory
criteria for true vitiligo. His lesions consisted of
hypo- rather than depigmented macules with
poorly demarcated borders close to the midline
of the back (Fig. 13). Histopathological exami-
nations of a biopsy taken from one of these lesions
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were normal. Skin scrapings were negative for
T. versicolor. As mentioned above, the borders
were poorly demarcated and not hyperpigmented
as we so often see in vitiligo.
Dopa positive melanocytes and cells containing
argentaffine granules were present in the split
skin specimen from the hypopigmented macules.
However, the dopa reactions and the silver
reactions were slightly less uniform and less
intense in the involved skin than in the normally
pigmented skin of the patient (Figs. 14, 15).
It is interesting that this patient failed to
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Fios. 6, 7 and 8. Vitiligo, post-treatment. Split epidermis, Dopa. 100X
Fiu. 6. Normally pigmented skin.
FIG. 7. Mottled repigmented skin. Note the cells are larger than the melanocytes in the normally
pigmented skin.
FIG. 8. Vitiliginous skin with hyperpigmented borders. Note the large polydendritie dopa-positive
melanocytes at one side and small "inactive" melanoeytes on the other.
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repigment following local methoxsalen and
intense artificial ultraviolet light exposures
once weekly for 6 weeks. However, he repig-
mented completely within 2 weeks while sun-
bathing in Florida. This was accomplished
without the use of psoralens in any form.
3) Congenital vitiligo
These cases were previously diagnosed as
localized albinism. Both of these patients had
depigmented patches present at birth. We will
discuss these 2 cases separately.
The first was a 16 year old white girl with a
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Fios. 9, 10 AND 11. Vitiligo, post-treatment. Dopa. 430X
FIG. 9. Normally pigmented skin.
Fios. 10 AND 11. Mottled repigmented skins. The melanocytes in this area are larger and more den-
dritic than those in the normally pigmented skin of the same patient.
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FIG. 12. Vitiligo, border area. Split epidermis, Masson's silver technic. 100X
Note sheets of silver positive epidermal cells in the hyperpigmented skin in contrast to the silver
negative vitiliginous area. There are a few islands of weakly silver positive cells in the intermediate
zone.
TABLE II
Results after oral methoxsalen and ultraviolet light therapy in one patient
Silver
Dopa
Methylene blue
Mottled Areas or Hyperpigmented
Borders
positive in areas
positive in areas
large polydendritic cells
positive in areas
large polydendritic cells
large depigmented patch on the left leg. When
first seen in our clinic she had already begun to
show some evidence of spontaneous repigmenta-
tion. Prior to the institution of methoxsalen
therapy, dopa-positive melanocytes as well as
cells containing silver positive granules were
present in the skin of the depigmented areas and
in areas which appeared to be repigmenting
(these areas were darker than her normal skin).
A biopsy specimen taken for histological exami-
nation from the darker areas failed to reveal
the presence of nevus cells. The melanocytes in
the depigmented and in the normal skin were
similar in morphology and staining reactions.
These melanocytes would be classified as normal
melanocytes. As would be expected, the melano-
cytes in the hyperpigmented areas were larger,
more complex and dendritic than those seen in
her normal skin. These cells resembled those
pigment cells activated by irradiation. We were
not surprised when this patient repigmented
almost completely with systemic methoxsalen
and ultraviolet light therapy, since her pretreat-
ment split skin specimen revealed the presence
of large numbers of cells containing argentaffine
granules as well as dopa-positive cells. The
Normal Skin
positive
positive
positive
Repigmented Areas
positive as control
positive as control
positive as control
Depigmented
Areas
negative
negative
negative
274 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Fie. 13. Pseudovitiligo
repigmented areas in this patient revealed the
presence of both normal and the larger, more
dendritie melanocytes.
The second case was a Negro girl, aged 15,
who was born with a large area of depigmenta-
tion on the dorsum of the right hand; 4 months
prior to visiting our clinic she developed new
areas of depigmentation on her face and anterior
chest. At the time of our examination there
was no evidence of spontaneous repigmentation
as evidenced by the lack of hyperpigmented
borders or of islands of repigmentation within
the patch. Examination of split skin prior to
therapy revealed islands of silver positive cells
as well as "inactive" melanocytes; there were no
typical dopa-positive cells in these preparations
(Figs. 16, 17). After the patient had had methox-
salen therapy for 3 months small islands of
repigmentation were clinically evident inside of
the patches of recent vitiligo with no definite
evidence of repigmentation in her congenital
patch.
At the time of this writing no split thickness
specimens have been taken at the area of re-
pigmentation.
II. Vitiligo in tissue culture
When skin specimens from vitiliginous areas
were cut for explantation, the depigmented
skins were found to be more firm than normal
and difficult to cut. This skin appeared to be more
fibrous than the normal skin from the same
area. In tissue culture the predominant out-
growth from vitiliginous skins appeared to be
fibroeytie; only rarely did extensive epithelial
sheet outgrowth occur. In contrast, normal skin
outgrowth is more epithelial than fibrous. These
findings appeared to indicate some mesodermal
component in vitiligo.
The tissue culture specimens when treated in a
manner similar to split skin specimens gave
comparable results.
DIScUSSION
Repeatedly, it has been demonstrated that
melanocytes are present in approximately equal
numbers in the skins of all races. The melanoeytes
are identified by their morphological char-
acteristics and staining reactions. At present
there are only 2 ways of positively identifying a
melanocyte: 1) the dopa reaction, and 2) a
positive silver reaction consisting of intracyto-
plasmie argentaffine granules. The exact nature
and functional significance of the questionable
dopa-positive small cells which we have tenta-
tively called "inactive" melanoeytes in this
paper remain obscure. These cells appear to be
smaller and less stellate than normal melanocytes.
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FIGs. 14 AND 15. Pseudovitiligo. Split epidermis, Masson's silver technic
FIG. 14. Hypopigmented skin. bOX. Note the relatively uniform distribution of the silver positive
cells
FIG. 15. Same. 430X
FIGs. 16 AND 17. Congenital vitiligo. Split epidermis, Masson's silver technic. Islands of silver positive
cells.
FIG. 16. Depigmented skin. bOX. Compare the distribution of the silver positive cells with that of
pseudovitiligo.
FIG. 17. Same. 430X
and are found sparsely scattered in preparations
of vitiliginous skin. In 2 of our eases of typical
vitiligo we found small islands of cells containing
argcntaffine granules in their cytoplasm. The
positive silver reaction in these cells tends to
indicate some enzyme activity in the pigment
cells. It should be noted that the arrangement
of these cells containing argentaffine granules
___ 'I
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FIG. 18. Pigment spread into the scar of a partially excised compound nevus
differs markedly from the arrangement of the
melanocytes in normal and from the "inactive"
melanocytes in vitiliginous skin. These cells are
arranged in small islands or groups in contrast
to the single cell arrangement of the melanocytes
shown in the dopa reaction. We do not believe
these islands of cells are entirely made up of
melanocytes; on the contrary we are of the
opinion that the islands consist of both melano-
cytes and epithelial cells. It appears significant
that these two cases of vitiligo were relatively
good pigmenters under the influence of methox-
salen therapy.
With the exception of the 2 cases just men-
tioned, there was an absence of typical dopa-
positive melanocytes as well as an absence of
islands of cells containing argentaffine granules
in all our cases of typical vitiligo. It is our im-
pression that these were the vitiliginous patients
whose repigmentation was classified as clinically
unsatisfactory.
Jarrett and Szabo (8) classified vitiligo into 2
main types, i.e. absolute and relative. The
absolute type was found to be completely lacking
in dopa-positive melanocytes. We believe the
so-called absolute vitilige of Jarrett and Szabo
does contain "inactive" melanocytes. These
authors classified the relative type of vitiligo
into 2 subtypes. Subtype I had melanocytes
which were slightly dopa-positive and which
were present in normal numbers; subtype II had
a reduced number of larger, more dendritic
dopa-positive melanocytes. With respect to
subtype I, we found only one case of vitiligo
(not included in this study) which exhibited
relatively normal numbers of "inactive" melano-
cytes with a questionable dopa reaction. All
our cases included in this study showed reduced
numbers of these cells. With respect to subtype
II, it is our impression that the larger, more
dendritic dopa-positive melanocytes are found
only in the pigmenting borders and in sites
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showing perifollicular repigmentation. These
hyperpigmented borders and islets of repigmenta-
tion are found both in patients repigmenting
spontaneously (usually in the summer) and in
patients receiving therapy with methoxsalen
and ultraviolet light. Most vitiligo patients will
show this type of melanocyte in some areas of
their skin. We do not believe that the presence
of the hyperpigmented border and/or the presence
of the larger, more dendritic dopa-positive
melanocytes necessarily indicates a good prog-
nosis for repigmentation.
In our studies, it appears that the presence of
silver positive cells in a vitiliginous area is a
better indicator for predicting repigmentation
than is the presence of dopa-positive cells of any
type, large or small. Our 2 cases of typical
vitiligo which responded readily to therapy
were those in which islands of cells with silver
positive granules were observed. It is interesting
that the one case of pseudovitiligo which con-
tained both dopa-positive and silver positive
cells repigmented completely on exposure to
natural sunlight. These aggregates of silver
positive cells were also present in the 2 cases of
congenital vitiligo which repigmented markedly
with treatment.
The fibrous nature of the vitiliginous skin
tends to indicate a dermal influence in this
disease. Any change in blood flow, gaseous ten-
sions and nutrition to the epidermis could
conceivably disturb the enzyme systems in both
epithelial cells and melanocytes. It is well known
that changes in temperature, pH, and substrate
concentrations affect enzyme actions. It is
possible that tyrosinase could be influenced by
such factors.
Haxthausen's transplantation experiments in
vitiligo (9) appear to support the existence of a
neurotrophic factor in the pathogenesis of
vitiligo. Other authors (10, 11) have not agreed
with this. Recently, Lerner et al. (12) succeeded
in demonstrating that melatonin, a lightening
agent for frog melanocytes, is present in human
peripheral nerves. Other evidence of increased
nervous activity are reports of increased sweating
(13) as well as vasoconstriction (14) in the
hypopigmented areas. In addition, the association
of emotional and traumatic shock preceding the
development of vitiliginous lesions is not an
unusual occurrence.
The hormonal influence on melanin pigmenta-
tion is well documented experimentally (15).
Even though it is not certain whether the pitui-
tary hormones and melatonin affect human
pigment cells in the same way as they do in the
aquatic animals, there is evidence to support the
concept that hormones do influence human
pigmentation.
One of our cases with rather extensive vitiligo
exhibited an almost complete repigmentation
within 3 months after a subtotal gastrectomy.
This was a 36 year old white female who had
extensive vitiligo of 22 years' duration. Under
the influence of methoxsalen and ultraviolet
light therapy she repigmented only moderately
but not completely. The patient voluntarily
discontinued her therapy and in a few months
lost all the pigment she had gained during the
therapy. She had a duodenal ulcer and atrophic
gastritis with marked hypochlorhydria. There
was no evidence of pernicious anemia. She was
operated 4 months ago. The patient stated that
she noticed spontaneous repigmentation soon
following her operation. When she was seen
approximately 3 weeks ago in our clinic, she had
repigmented more extensively than she ever had
during therapy with methoxsalen and ultra-
violet light. The findings in this case are interest-
ing when one thinks of the increased incidence
of pernicious anemia in vitiligo reported by Alli-
son and Curtis (16).
The existence of the hyperpigmented borders
around vitiliginous areas and the presence of
larger and more dendritic melanocytes in these
hyperpigmented borders are findings which are
worthy of note. It has been demonstrated that
pigment cells enlarge and become more dendritic
following various types of stimulation (17, 18);
therefore, it is difficult to understand why the
epithelial cells in the vitiliginous areas do not
receive pigment from the very active melanocytes
adjacent to them in the hyperpigmented border.
We have demonstrated pigment in epithelial
cells of normal skin which has been stimulated
by ultraviolet light. One must postulate some
transfer of pigment from the melanocytes to the
epithelial cells. In vitiligo one could postulate
some type of block between the dendrites of the
melanocytes and the epithelial cells. Staricco (18)
reported no increase in pigmentation in basal
cells following stimulation by thorium X. This
was interpreted by Staricco and Pinkus (2) to
indicate a temporary block under pathologic
conditions, which either does not permit the
melanocytes to discharge their granules, or
which, perhaps more probably, prevents the
malpighian cells from accepting pigment.
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The mechanism of pigment transfer, whether
accomplished by simple phagocytosis or by a
cytocrine process as proposed by Masson (4),
has not been confirmed. Our time-lapse cine-
matographic observations in tissue culture
preparations of human epidermal cells (19) tend,
however, to support the latter theory.
It is not known whether repigmentation is
initiated by the reactivation of "inactive"
melanocytes in the vitiliginous skin or whether
it is the result of the proliferation and migration
of active melanocytes from the normal skin and
the hair matrix melanocytes to the diseased
areas. The repigmentation appears to result
from the coalescence of perifollicular pigmenta-
tion and inward extension of the pigmented
border at the periphery of the vitiliginous patch.
We are inclined to favor the migration theory.
In addition, the observation of return of pig-
mentation in vitiligo following dermabrasion (20)
is more evidence in favor of the migration of
the melanocytes from the hair matrix cells.
The spread of pigment across the scar from a
partially excised nevus is in all probability
another example of melanocyte migration (Fig.
18).
Becker (21) studied the effect of combined
psoralen and ultraviolet light on normal skin and
concluded that the main effect of this therapy
was to increase the thickness of the stratum
corneum of the epidermis. It was his opinion that
the increased pigmentation which resulted was
due to the decreased shedding of the pigment
from the surface of the epidermis. It is well
known that a thickened epidermis offers good
protection against sunburn while increased
pigmentation or tanning which follows later
serves as additional protection (22). At least
part of the beneficial effect of psoralen on vitiligo
could then be attributed to the protection against
sunburn which permits the individual to tolerate
longer exposure to light. By the same token
melanocytes receiving longer exposure to sun-
light would be more apt to form pigment. It is
hard to believe that the entire systemic effect of
psoralens can be explained by the mechanism
just mentioned. It would indeed be interesting
to compare the effect of oral and parenteral
psoralens, should the latter become available for
investigative studies.
A different mechanism is involved in the
topical use of psoralens. Psoralens are well known
photosensitizing agents. When the skin is painted
with a solution of this drug and subsequently
exposed to sunlight, a sunburn is produced more
readily than in untreated skin. It is possible that
the inflammatory reaction with associated
hyperemia and increase in skin temperature
results in the stimulation of the melanogenic
activity in the melanocytes. This reaction may
well be comparable to post-inflammatory hyper-
pigmentation which occurs in normal skin.
In the study of vitiligo one question seems to
be of prime importance: On what factors does a
favorable response to therapy depend? We feel
that there are 3 main requisites: 1) melanocytes
which are capable of forming pigment under
stimulation must be present in the diseased
sites, 2) there must be the capacity for the
proliferation and/or migration of active melano-
cytes from adjacent normally pigmented areas
to the vitiliginous areas, and 3) the ability of the
epithelial cells to receive pigment from the
melanocytes must be intact. Our results appear
to indicate that all three factors are involved.
The presence of silver positive granules in the
epidermal cells with or without typical dopa-
positive melanocytes in the diseased skin serves
as indirect evidence for the existence of a po-
tentially active tyrosinase system in the melano-
cytes of that area. The presence of these granules
also appears to indicate the ability of the melano-
cytes to transfer pigment to the epithelial cells
of the epidermis.
CONCLUSIONS
Data from cytological studies of 18 cases of
vitiligo are presented. Included are 15 cases of
typical vitiligo, 2 cases of congenital vitiligo and
1 case classified as pseudovitiligo.
Our results appear to indicate that a favorable
response to combined methoxsalen and ultra-
violet light therapy depends on 3 basic mech-
anisms: 1) the presence of melanocytes which are
capable of forming pigment (shown by dopa
reaction), 2) the capacity for proliferation and/or
migration of active melanocytes from adjacent
pigmented areas to vitiliginous areas, and 3)
the ability of epithelial cells to receive pigment
from the active melanocytes (shown by silver
technic).
We would like to propose that a factor, equal
in importance to the presence of melanocytes
capable of forming melanin pigment, is operative
in cases of vitiligo which fail to repigment follow-
ing methoxsalen therapy. It is our opinion that
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this factor is closely related to the transfer of
pigment from the melanocytes to the epithelial
cells. We believe that the best method for demon-
strating this ability of pigment transfer is by
silver staining.
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DISCUSSION
DR. SAMUEL BECKER (Los Angeles, Cal.):
This very interesting presentation illustrates the
advantages of the use of some of the modern
methods in the study of the pigment cells.
Years ago I studied patches of vitiligo with
the dopa reaction en bloc, and with Masson
trichrome stain. I found after ultraviolet therapy
there is strong dopa reaction at the border, that
the melanocytes are branched with quite an
inflammatory infiltrate extending up into the
epidermis. In the center of the lesion, there was
no inflammatory infiltrate. The melanocytes
could be seen as very small cells in between the
basal cell.
Dr. Hu does not mention the duration of the
vitiliginous plaques. I think that is an important
consideration. If the plaque has only been there
from six months to a year it is not difficult to
produce repigmentation. If it has been there
for 20 years, it is practically impossible.
DR. LEON GOLDMAN (Cincinnati, Ohio): In
the vein which Dr. Becker just mentioned, I
would like to ask Dr. Hu about her concept of
migration of melanocytes into a scar. I think
that is of clinical importance. In conferences
with the plastic surgeons about the complete
excision of junctional nevi especially in the
prepuberty period, and more so in infants, there
have been a number of cases in which pigment
has recurred in the exact center of the scar. This
could not be due to incomplete excision or
could not be due to any deep appendageal source,
or anything like that at all. The question of the
migration of melanocytes and transference into
junction nevi was considered although we had
no proof. I would like to ask Dr. Hu whether it
does occur more easily in children and whether
it could be responsible for the recurrence in the
post operative scar.
DR. GEORGE C. ANDREWS (New York, N.Y.):
I hope that it will not be improper to inject a
little clinical material in this discussion of Dr.
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Hu's interesting paper. Recently in Buenos
Aires, Professor Aaron Kaminsky at the Israel
Hospital demonstrated some 20 cases of vitiligo
that had been treated by tattooing with Solganal
B (Sehering) which is a gold preparation. They
are convinced they get better results when they
use Solganal B than from tattooing alone. The
cases were all cured or practically cured of the
lesions on the face and neck. But they get no
benefits on the hands and wrists.
I have, since coming home, tattooed with
Solganal B, eases on the face and neck with ex-
cellent results. Usually eight or ten weekly treat-
ments brings back the pigment entirely. I
mention this in connection with Dr. Hu's paper.
I wonder if she has any explanation as to why
you do not get clinical improvement on the hands
and wrists.
Dn. HERMANN PINKU5 (Monroe, Mich):
Dr. Staricco in our department has just con-
cluded some work showing that the outer root
sheath of hair follicles contains inactive melano-
cytes, and that these, and possibly melanocytes
of the hair matrix move upward after planing
operations and repopulate the epidermis. This
will be published soon.
Da. FUNAN Hu (in closing): I would like,
first of all, to thank Drs. Becker, Goldman,
Andrews and Pinkus for their comments and
discussions.
With regard to Dr. Becker's question, in the
two patients who repigmented rather extensively,
one had the disease for 3 months prior to therapy,
while the other had it for 30 years. It appears
from these two examples that the duration of the
disease makes little difference in the capacity
to repigment. The patient who repigmented cx-
tensively following a subtotal gastrectomy also
had the disease for more than 20 years.
I do feel that the melanocytes arc capable of
migration. The presence of pigmented spots in
the scar following partial removal of a pigmented
nevus, the repigmentation of vitiliginous patches
as the result of coalescence of perifollicular
pigmentation and inward extension of the pig-
mented border, and the return of pigment in
vitiligo following dermabrasion all appear to
indicate melanocyte migration.
I cannot answer Dr. Goldman's question as to
whether or not migration of melanocytes occurs
more easily in children, since my experience in
dealing with removal of nevi in children is rather
limited. However I am inclined to believe that
the recurrence of pigment in the postoperative
scar could easily be due to the migration of
pigment cells from the neighboring parts.
I am glad that Dr. Andrews asked the question
about the failure of improvement of vitiliginous
patches of hands and wrists. The presence of
silver positive cells in the vitiliginous patch only
indicates the likelihood of repigmentation in that
particular area. It does not mean that all the
lesions in the patient will improve similarly.
We all have seen patients who may repigment
readily in some areas while other areas fail to
repigment no matter what you do.
From the observations on the few cases in-
cluded in the present study it is not possible to
draw any definite conclusions other than a few
postulations as made in this presentation. It is
hoped that our findings may be substantiated
by further study and follow up of a large series
of eases so that eventually definite conclusions
can be made.
